7 results match your criteria: "Pacific Neuroscience Institute Foundation[Affiliation]"

Basic Science and Pathogenesis.

Alzheimers Dement

December 2024

Pacific Brain Health Center, Pacific Neuroscience Institute Foundation, Santa Monica, CA, USA.

Background: Brain accumulation of amyloid-ß (Aß) in plaques and neurons is the cause of AD neuropathology that is opposed by autologous monocyte/macrophages (MMs) in health but this defense fails in AD.

Method: RNAseq, immunochemistry of the brain, immunofluorescence, and confocal microscopy of macrophages.

Result: In the AD brain, MMs shuttle Aß from parenchyma to vessels, which develop vasculitis, causing amyloid-related imaging abnormalities (ARIAs).

View Article and Find Full Text PDF

Beyond the hippocampus: Amygdala and memory functioning in older adults.

Behav Brain Res

August 2024

Pacific Neuroscience Institute Foundation, Pacific Brain Health Center, 1301 20th St, Suite 250, Santa Monica, CA, USA; Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at the University of California, 855 Tiverton Dr, Los Angeles, CA, USA.

Background: Medial temporal lobe atrophy has been linked to decline in neuropsychological measures of explicit memory function. While the hippocampus has long been identified as a critical structure in learning and memory processes, less is known about contributions of the amygdala to these functions. We sought to investigate the relationship between amygdala volume and memory functioning in a clinical sample of older adults with and without cognitive impairment.

View Article and Find Full Text PDF

Alzheimer's disease (AD) is a progressive neurodegenerative disease characterized by cognitive decline and atrophy in the medial temporal lobe (MTL) and subsequent brain regions. Structural magnetic resonance imaging (sMRI) has been widely used in research and clinical care for diagnosis and monitoring AD progression. However, atrophy patterns are complex and vary by patient.

View Article and Find Full Text PDF

Neuroinflammation: A Modifiable Pathway Linking Obesity, Alzheimer's disease, and Depression.

Am J Geriatr Psychiatry

October 2023

Mallinckrodt Institute of Radiology, Washington University in St. Louis, St. Louis, MO; Department of Neurology, Washington University in St. Louis, St. Louis, MO. Electronic address:

Obesity, depression and Alzheimer's disease (AD) are three major interrelated modern health conditions with complex relationships. Early-life depression may serve as a risk factor for AD, while late-life depression may be a prodrome of AD. Depression affects approximately 23% of obese individuals, and depression itself raises the risk of obesity by 37%.

View Article and Find Full Text PDF

This literature review summarizes the existing research examining the CNS penetration effectiveness (CPE) score and neurocognitive outcomes (i.e., neuropsychological assessment and neurocognitive screening) in HIV+ individuals.

View Article and Find Full Text PDF

Covarying structural alterations in laterality of the temporal lobe in schizophrenia: A case for source-based laterality.

NMR Biomed

June 2020

Tri-institutional Center for Translational Research in Neuroimaging and Data Science (TReNDS), Georgia State University, Georgia Institute of Technology, Emory University, Atlanta, Georgia, USA.

The human brain is asymmetrically lateralized for certain functions (such as language processing) to regions in one hemisphere relative to the other. Asymmetries are measured with a laterality index (LI). However, traditional LI measures are limited by a lack of consensus on metrics used for its calculation.

View Article and Find Full Text PDF